Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2021 4
2022 4
2023 4
2024 4
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune encephalitis: what the radiologist needs to know.
Sanvito F, Pichiecchio A, Paoletti M, Rebella G, Resaz M, Benedetti L, Massa F, Morbelli S, Caverzasi E, Asteggiano C, Businaro P, Masciocchi S, Castellan L, Franciotta D, Gastaldi M, Roccatagliata L. Sanvito F, et al. Among authors: businaro p. Neuroradiology. 2024 May;66(5):653-675. doi: 10.1007/s00234-024-03318-x. Epub 2024 Mar 20. Neuroradiology. 2024. PMID: 38507081 Free PMC article. Review.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Safety and efficacy of chronic weekly rozanolixizumab in generalized myasthenia gravis: the randomized open-label extension MG0004 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Kaminski HJ, Mantegazza R, Sacconi S, Utsugisawa K, Vu T, Boehnlein M, Gayfieva M, Greve B, Woltering F, Vissing J; MG0004 study investigators. Bril V, et al. J Neurol. 2025 Mar 19;272(4):275. doi: 10.1007/s00415-025-12958-9. J Neurol. 2025. PMID: 40105996 Free PMC article. Clinical Trial.
RFC1 expansions are a common cause of idiopathic sensory neuropathy.
Currò R, Salvalaggio A, Tozza S, Gemelli C, Dominik N, Galassi Deforie V, Magrinelli F, Castellani F, Vegezzi E, Businaro P, Callegari I, Pichiecchio A, Cosentino G, Alfonsi E, Marchioni E, Colnaghi S, Gana S, Valente EM, Tassorelli C, Efthymiou S, Facchini S, Carr A, Laura M, Rossor AM, Manji H, Lunn MP, Pegoraro E, Santoro L, Grandis M, Bellone E, Beauchamp NJ, Hadjivassiliou M, Kaski D, Bronstein AM, Houlden H, Reilly MM, Mandich P, Schenone A, Manganelli F, Briani C, Cortese A. Currò R, et al. Among authors: businaro p. Brain. 2021 Jun 22;144(5):1542-1550. doi: 10.1093/brain/awab072. Brain. 2021. PMID: 33969391 Free PMC article.
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.
Milano C, Saylam E, Papi C, Marmolejo L, Sankovic A, Reinecke R, Kerstens J, Pizzanelli C, Simabukuro MM, Benaiteau M, Joubert B, Gastaldi M, Dutra LA, Leypoldt F, Jansen M, Kawachi I, Akiyama H, Boy N, Bozzetti S, Christensen PB, Businaro P, Dinoto A, Friedman-Korn T, Fujiwara U, Fukumoto T, Fuse K, Hooshmand SI, Hurst L, Iorio R, Korn-Lubetzki I, Rodrigues AFL, Mariotto S, Michael J, Morimoto Y, Neuteboom RF, Piquet AL, Rossetti AO, Rumpler-Kreiner S, Santoro JD, Schwendinger F, Shen B, Syrbe S, Troger J, Wagner I, Bien CG, Martinez-Hernandez E, Armangue T, Höftberger R, Iizuka T, Titulaer MJ, Honnorat J, Graus F, Dalmau JO, Magaña S, Spatola M. Milano C, et al. Among authors: businaro p. Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200453. doi: 10.1212/NXI.0000000000200453. Epub 2025 Jul 18. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40680249 Free PMC article.
Clinical, prognostic and pathophysiological implications of MOG-IgG detection in the CSF: the importance of intrathecal MOG-IgG synthesis.
Greco G, Risi M, Masciocchi S, Businaro P, Rigoni E, Zardini E, Scaranzin S, Morandi C, Diamanti L, Foiadelli T, Giannoccaro MP, Morelli L, Liguori R, Barone P, Tozzo A, Passarini A, Gelibter S, Patti F, Banfi P, Simone AM, Bisecco A, Ruggieri M, Maimone D, Bruno G, Siliquini S, Bova S, Di Filippo M, Lanzillo R, Gallo A, Colombo E, Franciotta D, Gastaldi M; Neuroimmunology Platform (PNI) study group. Greco G, et al. Among authors: businaro p. J Neurol Neurosurg Psychiatry. 2024 Nov 18;95(12):1176-1186. doi: 10.1136/jnnp-2024-333554. J Neurol Neurosurg Psychiatry. 2024. PMID: 38844341
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (I): Antibodies to Intracellular Antigens.
Milano C, Businaro P, Papi C, Arlettaz L, Marmolejo L, Naranjo L, Gastaldi M, Iorio R, Saiz A, Planagumà J, Aguilar E, Pizzanelli C, Martinez-Hernandez E, Armangué T, Guasp M, Ruiz-García R, Sabater L, Dalmau JO, Graus F, Spatola M. Milano C, et al. Among authors: businaro p. Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200410. doi: 10.1212/NXI.0000000000200410. Epub 2025 May 20. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40393022 Free PMC article.
Assessing Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders (II): Antibodies to Surface Antigens.
Papi C, Milano C, Arlettaz L, Businaro P, Marmolejo L, Naranjo L, Planagumà J, Martinez-Hernandez E, Armangué T, Guasp M, Ruiz-García R, Aguilar E, Gastaldi M, Iorio R, Gaig C, Saiz A, Sabater L, Graus F, Dalmau JO, Spatola M. Papi C, et al. Among authors: businaro p. Neurol Neuroimmunol Neuroinflamm. 2025 Jul;12(4):e200406. doi: 10.1212/NXI.0000000000200406. Epub 2025 May 20. Neurol Neuroimmunol Neuroinflamm. 2025. PMID: 40393020 Free PMC article.
24 results